Lead Product(s) : Zoliflodacin,Azithromycin,Ceftriaxone
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : The Global Antibiotic Research and Development Partnership
Deal Size : Undisclosed
Deal Type : Agreement
Details : Through this MOU, the parties will seek to collaborate on efforts to determine market potential for zoliflodacin, therapeutic value to patients and explore possibilities to enter into future manufacturing and supply agreements.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
December 17, 2020
Lead Product(s) : Zoliflodacin,Azithromycin,Ceftriaxone
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : The Global Antibiotic Research and Development Partnership
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : Zoliflodacin,Azithromycin,Ceftriaxone
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Innoviva’s Zoliflodacin Phase 3 Data in Uncomplicated Gonorrhea Announced at ESCMID 2024
Details : Zoliflodacin, an antibiotic, is currently undergoing evaluation in late-stage clinical trials with patients for treating gonorrhea, in combination with ceftriaxone/azithromycin.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 24, 2024
Lead Product(s) : Zoliflodacin,Azithromycin,Ceftriaxone
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Zoliflodacin
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Parexel | KCAS Bio
Deal Size : Inapplicable
Deal Type : Inapplicable
Zoliflodacin Bioequivalence and Drug-Drug Interaction Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 02, 2022
Lead Product(s) : Zoliflodacin
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Parexel | KCAS Bio
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Zoliflodacin,Azithromycin,Ceftriaxone
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : The Global Antibiotic Research and Development Partnership
Deal Size : Undisclosed
Deal Type : Agreement
Details : Through this MOU, the parties will seek to collaborate on efforts to determine market potential for zoliflodacin, therapeutic value to patients and explore possibilities to enter into future manufacturing and supply agreements.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
December 17, 2020
Lead Product(s) : Zoliflodacin,Azithromycin,Ceftriaxone
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : The Global Antibiotic Research and Development Partnership
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : Zoliflodacin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Quotient Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Investigate Effect of Food and Safety of a New Formulation of Zoliflodacin
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 24, 2018
Lead Product(s) : Zoliflodacin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Quotient Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Zoliflodacin
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
AZD0914 Phase 1 ADME Study in Healthy Volunteers
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 24, 2014
Lead Product(s) : Zoliflodacin
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Zoliflodacin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD0914
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 28, 2013
Lead Product(s) : Zoliflodacin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable